Clinical Trial Update: 'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers [NA]

View source ↗

Summary

This clinical trial update notes the completion of study NCT05113264, evaluating Penny, an SMS-based chatbot to support medication adherence and side-effect man…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Gastrointestinal Cancer | NA | Status: COMPLETED